How to Identify Warning Signs of Severe Jelly Skin Complications

Scleroderma, also known as systemic sclerosis or colloquially referred to as “jelly skin,” is a complex autoimmune disorder that causes the skin to become tight, hardened, and shiny. While the term “jelly skin” may sound benign, this condition can lead to serious and potentially life-threatening complications if warning signs are not recognized and addressed promptly. Understanding the full spectrum of symptoms, complications, and risk factors associated with scleroderma is essential for early intervention and improved patient outcomes.

Understanding Scleroderma: More Than Just Skin Deep

Scleroderma involves the hardening and tightening of the skin and connective tissues, and some forms can affect internal organs. The condition causes your body to produce too much collagen, a protein needed for healthy skin and tissue, and it’s an autoimmune condition where your immune system attacks your body instead of protecting it.

Scleroderma is an autoimmune disease that causes inflammation and fibrosis (thickening) in the skin and other areas of the body, and when an immune response tricks tissues into thinking they are injured, it causes inflammation and the body makes too much collagen, leading to areas of tight, hard skin. The excess collagen deposits not only affect the skin but can also accumulate in blood vessels and internal organs, leading to severe complications.

Types of Scleroderma: Localized vs. Systemic

Understanding the type of scleroderma is crucial for assessing risk and recognizing warning signs of severe complications. There are two main categories of this condition, each with distinct characteristics and prognosis.

Localized Scleroderma

Localized scleroderma only affects the skin and the structures directly under the skin. Localized scleroderma primarily affects the skin and subcutaneous tissue, leading to patches of thickened skin, but it is not associated with Raynaud phenomenon, digital ischemic events, or internal organ involvement. Notably, localized scleroderma is not associated with increased mortality.

This form typically presents as morphea (patches of hardened skin) or linear scleroderma (bands of thickened skin). While localized scleroderma can cause cosmetic concerns and mobility issues, it generally does not pose the same life-threatening risks as systemic forms.

Systemic Sclerosis (Systemic Scleroderma)

Systemic scleroderma, also called systemic sclerosis, affects many systems in the body and is the more serious type of scleroderma that can damage blood vessels and internal organs, such as the heart, lungs, and kidneys. This form carries a significantly higher risk of severe complications and mortality.

Systemic sclerosis is further divided into subtypes:

Limited Cutaneous Systemic Sclerosis: This type comes on gradually and affects the skin on fingers, hands, face, lower arms, and legs below the knees. Previously known as CREST syndrome, it typically has a slower progression.
Diffuse Cutaneous Systemic Sclerosis: This type comes on more rapidly and starts as being limited to the fingers and toes, but then extends beyond the elbows and knees to the upper arms, trunk, or thigh. Diffuse cutaneous systemic sclerosis typically presents more severe symptoms and higher mortality rates compared to limited cutaneous systemic sclerosis, often involving internal organs more extensively and severely.
Systemic Sclerosis Sine Scleroderma: In this type, fibrosis affects one or more internal organs but not the skin. This rare form can be particularly challenging to diagnose because skin changes are absent.

Critical Warning Signs of Severe Scleroderma Complications

Recognizing the warning signs of severe complications is essential for timely medical intervention. The following symptoms should prompt immediate medical attention, as they may indicate serious organ involvement or life-threatening complications.

Some people develop violet-colored skin, which means that the scleroderma is active and expanding. This color change is a particularly concerning sign that requires prompt evaluation. Other critical skin manifestations include:

Rapid skin hardening: Skin that becomes tight and hard quickly, especially when spreading beyond the initial areas of involvement
Digital ulcers: When a person has a type of scleroderma that also affects the internal organs, it’s common to have skin sores that tend to develop on skin that is tightly stretched, especially on the fingers. Systemic scleroderma and Raynaud’s can cause painful ulcers on the fingers or toes, which are known as digital ulcers.
Calcinosis: Calcium deposits occur in the connective tissue beneath the skin, where you may feel one or more hard, painful lumps, and if a calcium deposit breaks through the skin, it can be very painful and you’ll see a white or yellow chalky substance, leading to infection and painful open sores.
Severe itching: Pruritus is a sign of active disease and has been linked to more severe skin and gastrointestinal tract involvement.
Telangiectasia: Tiny blood vessels near the surface of the skin swell, and you may see tiny red spots, usually on the hands and face.

Vascular Complications and Raynaud Phenomenon

Raynaud Phenomenon is the most common early symptom of systemic scleroderma and is present at one time or another in about 90 percent of patients. In Raynaud Phenomenon, the blood vessels constrict or narrow in response to cold or emotional upset and stress, causing a series of color changes in the skin: white, blanched, or pale when circulation is reduced; blue as the affected part loses oxygen from decreased blood flow; and then red or flushed as blood flow returns.

Warning signs that Raynaud phenomenon is becoming severe include:

Prolonged episodes lasting more than 20 minutes
Development of digital ulcers or sores on fingertips
Severe pain during or after episodes
Signs of tissue damage or gangrene
Digital ischemia may progress to gangrene, necessitating amputation.

Musculoskeletal Warning Signs

When the hard, thickening, or tight skin forms over a joint (such as the jaw, wrist, or finger), the tightness can make it difficult to move that joint, and patients may not be able to fully open their hands because of tight skin. Additional musculoskeletal complications include:

Scleroderma may cause chronic joint pain, inflammation and swelling in muscles and joints.
Progressive loss of range of motion in fingers, wrists, elbows, or other joints
Muscle weakness or atrophy
Tendon friction rubs (a creaking sensation when moving joints)
Contractures that prevent normal hand or limb function

Gastrointestinal Complications

Gastrointestinal involvement is extremely common in systemic sclerosis and can significantly impact quality of life and nutritional status. Fibrosis can affect internal organs and lead to impairment or failure of affected organs, with the most commonly affected organs being the esophagus, heart, lungs, and kidneys, and internal organ involvement may be signaled by heartburn, difficulty swallowing, high blood pressure, kidney problems, shortness of breath, diarrhea, or impairment of the muscle contractions that move food through the digestive tract.

Critical gastrointestinal warning signs include:

Severe dysphagia: Difficulty swallowing that worsens or prevents adequate nutrition
Persistent heartburn: Gastroesophageal reflux disease (GERD) that doesn’t respond to standard treatments
Malabsorption symptoms: The small intestine can become involved, leading to bacterial overgrowth and malabsorption of bile salts, fats, carbohydrates, proteins, and vitamins.
Severe constipation or pseudo-obstruction: When dysmotility affects the large intestine, chronic intestinal pseudo-obstruction can occur, mimicking true bowel obstruction with symptoms including nausea, vomiting, abdominal distention and changes in bowel movement.
Unintentional weight loss: Patients with severe gastrointestinal involvement can become profoundly malnourished.
Fecal incontinence: Loss of bowel control due to anorectal involvement

Pulmonary Complications: A Leading Cause of Mortality

Pulmonary involvement is the primary cause of morbidity, causing irreversible pulmonary fibrosis. Interstitial lung disease and pulmonary artery hypertension account for almost two-thirds of deaths related to systemic sclerosis. Early detection and treatment of lung complications are critical for survival.

Warning signs of pulmonary involvement include:

Progressive shortness of breath: Dyspnea that worsens over time, especially with exertion
Persistent dry cough: A chronic, non-productive cough that doesn’t resolve
Chest pain: Particularly if associated with breathing difficulties
Decreased exercise tolerance: Inability to perform activities that were previously manageable
Fatigue and weakness: Extreme tiredness that may indicate reduced oxygen levels
Signs of pulmonary hypertension: Dizziness, fainting, swelling in ankles or legs

Complications include interstitial lung disease, pulmonary arterial hypertension, and heart failure, among others. These conditions require specialized monitoring and treatment to prevent progression.

Cardiac Complications

Cardiac involvement can lead to constrictive pericarditis, pericardial fibrosis or effusions, and patchy myocardial fibrosis as significant findings. The heart and lungs are commonly affected by systemic sclerosis but usually remain asymptomatic in the early stages of the disease, and overt cardiopulmonary symptoms are associated with poor outcomes.

Cardiac warning signs include:

Irregular heartbeat or palpitations
Chest pain or pressure
Shortness of breath at rest or with minimal exertion
Swelling in the legs, ankles, or abdomen
Unexplained fatigue or weakness
Dizziness or fainting episodes

Scleroderma Renal Crisis: A Medical Emergency

Scleroderma renal crisis is a life-threatening complication of systemic sclerosis characterized by the abrupt onset of hypertension and oliguric acute kidney injury. It occurs in 10% of patients with diffuse systemic sclerosis and very seldom – 0.5% – in patients with limited systemic sclerosis.

Critical warning signs of scleroderma renal crisis include:

Sudden severe hypertension: Excessive proliferation and thickening of the vessel wall decreases renal blood flow and causes higher renin levels, leading to malignant hypertension.
Decreased urine output: Oliguria or anuria (little to no urine production)
Headaches: Severe, persistent headaches that may indicate dangerously high blood pressure
Visual disturbances: Blurred vision or other vision changes
Seizures: In severe cases
Confusion or altered mental status
Nausea and vomiting

Patients with scleroderma renal crisis can have permanent renal damage, although the use of ACE inhibitors leads to recovery of renal function in most cases. Regular blood pressure monitoring, both in the clinic and at home, is highly recommended, particularly in individuals recently diagnosed with diffuse cutaneous systemic sclerosis, those experiencing new-onset hypertension, or those with a significant worsening of existing hypertension, as it may signal the onset of scleroderma renal crisis.

Neurological Complications

Recent reports suggest that nervous system changes in systemic sclerosis may be directly related to the disease, and it is assumed that the same vascular lesions as in Raynaud’s phenomenon may occur in the brain and peripheral small vessels vascularizing peripheral nerves, leading to symptoms of nervous system involvement.

The most common nervous system symptoms include headache and dizziness, convulsions, visual disturbances and aphasia, and less common symptoms include anxiety, depression, psycho-organic syndromes, disturbances of cognition and orientation, and even loss of consciousness, as well as transient ischemic attack and/or other ischemic syndromes, strokes, trigeminal neuroinflammation, peripheral polyneuropathy and cranial nerve inflammation.

Systemic Warning Signs

Certain systemic symptoms may indicate widespread disease activity or complications:

Unexplained fever: May indicate infection, especially in the presence of digital ulcers or other skin breakdown
Profound fatigue: Constitutional symptoms are common, such as fatigue, arthralgia and myalgia.
Unintentional weight loss: May signal gastrointestinal involvement or malabsorption
New or worsening pain: Particularly in joints, muscles, or chest

Risk Factors for Severe Complications

Certain factors increase the risk of developing severe complications from scleroderma. Understanding these risk factors can help patients and healthcare providers maintain appropriate vigilance.

Disease Subtype

Among people with systemic sclerosis, those with diffuse cutaneous systemic sclerosis tend to have a worse prognosis than those with limited cutaneous disease. Diffuse systemic sclerosis, internal organ complications, and older age at diagnosis are associated with worse prognoses.

Autoantibody Profile

Specific autoantibodies are associated with different complication risks:

Anti-RNA polymerase III antibody: Associated with rapidly progressing and aggressive diffuse skin involvement, poor cutaneous outcomes, scleroderma renal crisis, and malignancies, but lower risk of interstitial lung disease and pulmonary arterial hypertension.
Anti-U3-RNP (fibrillarin) antibody: These antibodies are prevalent in African Americans and are associated with an overall poor prognosis in systemic sclerosis, with increased internal organ involvement, diffuse cutaneous manifestations, interstitial lung disease, pulmonary arterial hypertension, scleroderma renal crisis, myositis/myopathy, and cardiac complications.
Anti-centromere antibodies: These are most often positive in people with limited skin systemic sclerosis and in those who may develop pulmonary artery high blood pressure.

Demographic Factors

Systemic sclerosis tends to manifest more severely in males, African Americans, and individuals with a later age of onset. Scleroderma can affect people of all races and ethnic groups, but the disease can affect African Americans more severely.

Previous high dose (greater than 15 mg daily) prednisone administration has been considered as an independent risk factor for scleroderma renal crisis. Corticosteroids predispose patients to scleroderma renal crisis and thus should be avoided.

When to Seek Immediate Medical Attention

Call 911 or go to the emergency room if you feel like you’re having a heart attack, can’t breathe or can’t swallow. Additionally, seek emergency care for:

Sudden severe headache with very high blood pressure
Chest pain or pressure
Severe shortness of breath or inability to breathe
Sudden vision changes or loss of vision
Seizures or loss of consciousness
Signs of stroke (facial drooping, arm weakness, speech difficulty)
Severe abdominal pain with vomiting
Significantly decreased or absent urine output

When to Contact Your Healthcare Provider Promptly

Visit a healthcare provider if you’re experiencing symptoms like pain and stiffness in your joints, especially if you notice thickened skin around your fingers and toes. If you have a salt-and-pepper look on your skin, you should see a doctor, as this can be a sign that you have a type of scleroderma that affects internal organs, and the sooner you are diagnosed and treated, the better your prognosis.

Contact your healthcare provider promptly for:

New or worsening skin changes, especially rapid progression
Development of digital ulcers or non-healing sores
Increasing difficulty swallowing or persistent heartburn
Progressive shortness of breath or new cough
Unexplained weight loss
New joint pain or decreased range of motion
Worsening Raynaud phenomenon with prolonged episodes
Any new neurological symptoms
Persistent fever
Blood pressure readings consistently above 140/90 mmHg

Diagnostic Evaluation and Monitoring

Early and accurate diagnosis is essential for preventing severe complications. If you have symptoms that suggest scleroderma is affecting an internal organ, you should see a dermatologist, rheumatologist, or other doctor who treats scleroderma, and the sooner you are diagnosed and treated, the better your outcome.

Initial Diagnostic Workup

During a physical exam, doctors will look for thickened, tight, or shiny areas of skin and other signs of scleroderma, and will also listen to your lungs and heart for any abnormalities that could be caused by scleroderma.

Blood tests check for certain antibodies, including antinuclear autoantibodies (which are present when a person has an autoimmune disease; specific antibodies are particular to systemic scleroderma), and bloodwork also helps doctors rule out other conditions and determine which organs may be involved in the disease.

Ongoing Monitoring

Monitoring of progress and treatment response is vital in systemic sclerosis, and the skin is usually monitored clinically using the modified Rodnan Skin Score, which gives an indication of the extent and severity of cutaneous sclerosis, which also reflects the severity and risk of internal organ involvement.

Nailfold capillary examination is warranted in all patients presenting with Raynaud phenomenon and suspected systemic sclerosis, and a comprehensive physical examination of patients targeting multiple organ systems is conducted during each visit to detect underlying organ involvement.

Proactive and routine annual screening allows early intervention with disease-modifying drugs. Regular monitoring should include:

Pulmonary function tests and high-resolution CT scans for lung involvement
Echocardiography to assess for pulmonary hypertension and cardiac function
Blood pressure monitoring (both clinic and home measurements)
Kidney function tests
Gastrointestinal assessments as needed
Skin assessments using standardized scoring systems

Treatment Approaches for Preventing and Managing Complications

There is no cure for scleroderma, but your doctor can treat your symptoms and help prevent complications, and you will most likely need a combination of treatments, with your doctor helping you find the combination that eases your symptoms and minimizes how much they impact your day-to-day life.

Organ-Specific Treatments

Treatment is symptomatic and based on the extent of skin and internal organ involvement, and a multidisciplinary approach is recommended to address the complex and heterogeneous manifestations of systemic sclerosis.

For Raynaud Phenomenon and Digital Ulcers:

Vasodilators help widen your blood vessels, which may treat Raynaud’s phenomenon and some lung problems.
Calcium channel blockers
Phosphodiesterase-5 inhibitors for severe or refractory digital ulcers

For Skin Involvement:

Methotrexate, mycophenolate mofetil, tocilizumab, rituximab, IV immune globulin, and cyclophosphamide all have shown modest benefit.
Skin treatments, such as creams and moisturizers, to keep your skin from drying out, and ease tightness and itching.

For Gastrointestinal Complications:

Proton pump inhibitors for GERD
Prokinetic agents for motility issues
Antibiotics for bacterial overgrowth

For Pulmonary Complications:

Immunosuppressive therapy for interstitial lung disease
Pulmonary vasodilators for pulmonary arterial hypertension

For Scleroderma Renal Crisis:

Management of scleroderma renal crisis includes initiation or uptitration of ACE inhibitors and nephrology consultation.

Immunosuppressive Therapy

Immunosuppressants stop your immune system from damaging your cells and tissues, and for instance, immunosuppressive therapy, such as methotrexate, can help control inflammation and prevent tissue scarring and damage. In diffuse cutaneous disease or severe organ involvement, systemic immunomodulatory medication is indicated.

Lifestyle Modifications and Self-Care Strategies

Patient education plays a crucial role in disease management, including lifestyle adjustments, and individuals with Raynaud phenomenon should be educated on maintaining body and extremity warmth, avoiding extreme cold exposure, vasoconstrictive agents, and trauma to the digits.

Protecting Against Cold Exposure

Those with Raynaud phenomenon should dress warmly and avoid cold weather when possible. Specific strategies include:

Wearing insulated gloves and warm socks
Using hand and foot warmers in cold weather
Avoiding air conditioning directed at hands or feet
Warming the car before driving in cold weather
Using insulated cups for cold beverages

Skin Care

Excessive dryness of the skin may lead to skin breakdown and ulcerations, excessive bathing and hand washing should be avoided, and rubber gloves worn to avoid direct contact with household detergents, and keeping the skin moist and well-lubricated is important to avoid complications from dry skin.

Bath oils and moisturizing soaps are preferable to harsh soaps which dry out the skin, and frequent use of moisturizing skin creams containing lanolin is advised.
Apply moisturizers immediately after bathing to lock in moisture
Use a humidifier, especially during winter months
Protect skin from injury and trauma

Oral and Dental Care

People with scleroderma may experience a general tightening of skin over the face, and the opening of the mouth may be decreased in size (microstomia or small mouth), making lip and mouth movements as well as oral hygiene difficult, and the best approach to treatment is by means of facial grimacing and mouth stretching exercises, including the use of oral augmentation props inserted between the upper and lower teeth.

Preventive dental care including regular flossing and brushing of the teeth and gums is very important, as are regular dental visits for oral health and for the early detection and prompt correction of any abnormalities.

Gastrointestinal Management

People with acid reflux may elevate the head of their bed to help relieve symptoms. Additional strategies include:

Eating smaller, more frequent meals
Avoiding trigger foods (spicy, acidic, fatty foods)
Not eating within 2-3 hours of bedtime
Maintaining adequate hydration
Working with a dietitian for nutritional support if malabsorption is present

Exercise and Physical Therapy

Regular exercise and physical therapy can help maintain joint mobility and muscle strength:

Range-of-motion exercises for hands and joints
Stretching exercises to prevent contractures
Low-impact aerobic exercise as tolerated
Occupational therapy for adaptive strategies

Smoking Cessation

Encourage smoking cessation. Smoking constricts blood vessels and can worsen Raynaud phenomenon, increase the risk of digital ulcers, and accelerate lung disease progression.

The Importance of a Multidisciplinary Care Team

Systemic scleroderma results in significant morbidity, causing severe disability without a known cure and only offering symptomatic treatment, and due to its impact on multiple organ systems, a collaborative interprofessional healthcare team approach is necessary, including the patient’s primary care clinician, rheumatologists, gastroenterologists, cardiologists, pulmonologists, nephrologists, and dermatologists.

Nurses and pharmacists are critical in patient care for systemic sclerosis, patients with scleroderma require close follow-up by healthcare providers, and nursing staff are essential for patient education, monitoring, and follow-up care, and they can also coordinate activities among healthcare professionals involved in the patient’s treatment.

A comprehensive care team ensures:

Regular monitoring for organ involvement
Coordinated treatment plans
Early detection of complications
Patient education and support
Medication management and monitoring for side effects
Psychosocial support for coping with chronic illness

Prognosis and Long-Term Outlook

The outlook for people with scleroderma varies greatly, depending on their type of scleroderma, which organs are involved, and the severity of the disease. In general, people with systemic scleroderma are at greater risk of complications or death than those with localized scleroderma.

Those with localized disease generally have a normal life expectancy, but in those with systemic disease, life expectancy can be affected and varies based on subtype, with death often due to lung, gastrointestinal, or heart complications.

A 2018 study placed 10-year survival rates at 88%, without differentiation based on subtype, and diffuse systemic sclerosis, internal organ complications, and older age at diagnosis are associated with worse prognoses.

Systemic sclerosis is still undoubtedly a challenge for clinicians because of the variety of symptoms, and the course and prognosis depend on clinical picture and character of organ involvement (kidney, heart and lungs in particular), and the treatment should be carried out by rheumatologists consulting other specialists, and although early diagnosis and new therapeutic options significantly improve prognosis, it is still characterized by a severe course and high risk of early death.

Emerging Research and Future Directions

Research into scleroderma continues to advance, with ongoing studies investigating:

Novel immunosuppressive and antifibrotic therapies
Targeted biologic agents
Autologous hematopoietic stem cell transplantation is based on the assumption that autoimmune diseases such as systemic sclerosis occur when the white blood cells of the immune system attack the body.
Biomarkers for early detection and disease monitoring
Genetic factors contributing to disease susceptibility and severity
Improved screening methods for organ involvement

Conclusion: Vigilance and Early Intervention Are Key

Scleroderma, or “jelly skin,” is far more than a cosmetic concern—it is a complex autoimmune disease that can lead to severe, life-threatening complications affecting multiple organ systems. Scleroderma can cause life-threatening complications if it affects tissue in your organs. Understanding and recognizing the warning signs of severe complications is absolutely critical for timely intervention and improved outcomes.

Key takeaways for patients and caregivers include:

Learn to recognize the warning signs of organ involvement, particularly pulmonary, cardiac, renal, and gastrointestinal complications
Maintain regular follow-up with a multidisciplinary healthcare team
Monitor blood pressure regularly at home, especially if you have diffuse systemic sclerosis
Seek immediate medical attention for emergency warning signs
Adhere to prescribed treatments and lifestyle modifications
Participate in routine screening for organ involvement
Stay informed about your specific disease subtype and associated risks

While there is currently no cure for scleroderma, early recognition of complications, prompt treatment, and comprehensive disease management can significantly improve quality of life and long-term outcomes. With advances in understanding the disease mechanisms and the development of new therapies, the prognosis for patients with scleroderma continues to improve.

If you or a loved one has been diagnosed with scleroderma, work closely with your healthcare team to develop a personalized monitoring and treatment plan. Stay vigilant for warning signs, maintain open communication with your providers, and don’t hesitate to seek medical attention when concerning symptoms develop. Early intervention can make a critical difference in preventing severe complications and preserving organ function.

For more information about scleroderma and support resources, visit the National Scleroderma Foundation, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, or consult with a rheumatologist who specializes in autoimmune connective tissue diseases.

Table of Contents